Psychiatry 96 , 7684 (2024)
One systematic review and meta-analysis with over 6,000 participants showed GLP-1s significantly improved levels of C-reactive protein, which is a marker of inflammation, among people with type 2 diabetes
Retatrutide raises resting heart rate by around 6.7 bpm at 12 mg in the Phase 2 trial
Gastroparesis-like symptoms associated with Ozempic, Wegovy, Mounjaro and other GLP-1 receptor agonists may resolve after stopping use of the medications
calories: 12401570 Approx
Regulatory bodies like the FDA and EMA necessitate thorough physicochemical characterisation, stability information, and proof of therapeutic equivalency, which can be challenging for these heterogeneous systems [124]